Alzheimer Vaccine to Get Trial


Singapore - Today reported on Novartis plans to conduct trials of its Alzheimer’s vaccine in the city state, among other sites. Reporting from what was billed as the Novartis Biotechnology Leadership Camp” here, the daily quoted officials saying a vaccine could be available in perhaps five to seven years. That will probably be too late for Singapore’s current 22,000 Alzheimer sufferers, but not for the 187,000 this tiny republic is projected to have in 45 years. Paul Herrling, the pharma’s head of corporate research, explained the object of the exercise this way: “What we try to do is use the immune system to clear the brain of one little piece of protein that seems to be killing the nerve cells.&rdquo